USD 0.38
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| AAWH | 2.7 | -7.3 | -2.6 | -57.2 | -60.8 | -69.8 | -91.7 | -96.0 | -96.0 | -96.0 |
| S&P 500 | 0.1 | 1.6 | 2.0 | 5.1 | 9.7 | 25.3 | 38.2 | 83.3 | 197.0 | 34407.9 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | AAWH |
| name | Ascend Wellness Holdings, Inc. |
| price | 0.38 |
| changes percentage | 2.7027 |
| change | 0.01 |
| day low | 0.37 |
| day high | 0.4 |
| year high | 1.82 |
| year low | 0.33 |
| market cap | 81458700 |
| price avg 50 | 0.43522 |
| price avg 200 | 0.867145 |
| exchange | PNK |
| volume | 5138 |
| avg volume | 343561 |
| open | 0.37 |
| previous close | 0.37 |
| eps | -0.41 |
| pe | -0.93 |
| earnings announcement | 2025-03-18T12:00:00.000+0000 |
| shares outstanding | 214365000 |
| timestamp | 2025-01-23 16:43:45 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001756390 | |||
| revenue | 518590000 | 405926000 | 27.75 |
| gross profit | 155120000 | 134563000 | 15.28 |
| gross profit ratio | 0.3 | 0.33 | -9.77 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 158739000 | 136744000 | 16.08 |
| interest income | 0 | 32436000 | -100.00 |
| interest expense | 36984000 | 30256000 | 22.24 |
| ebitda | 82260000 | 27376000 | 200.48 |
| ebitdaratio | 0.16 | 0.09 | 74.89 |
| operating income | -3619000 | -1425000 | -153.96 |
| operating income ratio | -0.01 | -0.0 | -98.79 |
| net income | -48214000 | -80899000 | 40.40 |
| net income ratio | -0.09 | -0.2 | 53.35 |
| eps | -0.24 | -0.44 | 45.45 |
Revenue Growth: revenue increased to 519 million in 2023 from 406 million in 2022 representing a change of 27.75%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 155 million in 2023 from 135 million in 2022 representing a change of 15.28%. This indicates a sales profitability growth, which is a positive sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 82 million in 2023 from 27 million in 2022 representing a change of 200.48%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to -4 million in 2023 from -1 million in 2022 representing a change of -153.96%. The increase in operating income indicates better operational performance and increased profitability.
Earnings per Share (EPS): EPS increased to -0.24 in 2023 from -0.24 in 2022 representing a change of 45.45%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Operating Expenses: Operating Expenses increased to 159 million in 2023 from 137 million in 2022 representing a change of 16.08%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
Net Income: Net income decreased to -48 million in 2023 from -81 million in 2022 representing a change of 40.4%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001756390 | |||
| revenue | 141647000 | 141536000 | 0.08 |
| gross profit | 43729000 | 41573000 | 5.19 |
| gross profit ratio | 0.31 | 0.29 | 5.10 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 46146000 | 43095000 | 7.08 |
| interest income | 0 | 0 | NaN |
| interest expense | 11006000 | 8535000 | 28.95 |
| ebitda | 9631000 | 15189000 | -36.59 |
| ebitdaratio | 0.07 | 0.11 | -36.64 |
| operating income | -2417000 | -1522000 | -58.80 |
| operating income ratio | -0.02 | -0.01 | -58.68 |
| net income | -28256000 | -21784000 | -29.71 |
| net income ratio | -0.2 | -0.15 | -29.61 |
| eps | -0.13 | -0.1 | -30.00 |
Revenue Growth: revenue increased to 142 million in 2024Q3 from 142 million in 2024Q2 representing a change of 0.08%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 44 million in 2024Q3 from 42 million in 2024Q2 representing a change of 5.19%. This indicates a sales profitability growth, which is a positive sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 10 million in 2024Q3 from 15 million in 2024Q2 representing a change of -36.59%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to -2 million in 2024Q3 from -2 million in 2024Q2 representing a change of -58.8%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to -28 million in 2024Q3 from -22 million in 2024Q2 representing a change of -29.71%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Operating Expenses: Operating Expenses increased to 46 million in 2024Q3 from 43 million in 2024Q2 representing a change of 7.08%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
Earnings per Share (EPS): EPS increased to -0.13 in 2024Q3 from -0.13 in 2024Q2 representing a change of -30.0%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001756390 | |||
| total assets | 919550000 | 872160000 | 5.43 |
| total liabilities | 776678000 | 708745000 | 9.58 |
| total equity | 142872000 | 163415000 | -12.57 |
| cash and cash equivalents | 72508000 | 74146000 | -2.21 |
| short term investments | 9302000 | 3170000 | 193.44 |
| long term investments | -2101000 | 4018000 | -152.29 |
| total current assets | 228860000 | 198743000 | 15.15 |
| total non current assets | 690690000 | 673417000 | 2.56 |
| total current liabilities | 92686000 | 110949000 | -16.46 |
| total non current liabilities | 683992000 | 597796000 | 14.42 |
| common stock | 207000 | 188000 | 10.11 |
| retained earnings | -315362000 | -267148000 | -18.05 |
| total debt | 573460000 | 563075000 | 1.84 |
Total Assets: Total Assets increased to 920 million in 2023 from 872 million in 2022 representing a change of 5.43%. Suggesting a growth in asset holdings.
Short Term Investments: Short Term Investments increased to 9 million in 2023 from 3 million in 2022 representing a change of 193.44%. This indicates an increase in short-term investment holdings.
Total Current Assets: Total Current Assets increased to 229 million in 2023 from 199 million in 2022 representing a change of 15.15%. This indicates a better liquidity position.
Total Current Liabilities: Total Current Liabilities decreased to 93 million in 2023 from 111 million in 2022 representing a change of -16.46%. This indicates a lower short-term debt burden.
Common Stock: Common Stock increased to 0 in 2023 from 0 in 2022 representing a change of 10.11%. This indicates an increase in ownership interest.
Total Liabilities: Total Liabilities increased to 777 million in 2023 from 709 million in 2022 representing a change of 9.58%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to 143 million in 2023 from 163 million in 2022 representing a change of -12.57%. This indicates a decrease in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 73 million in 2023 from 74 million in 2022 representing a change of -2.21%. This indicates a decrease in available liquid assets.
Retained Earnings: Retained Earnings decreased to -315 million in 2023 from -267 million in 2022 representing a change of -18.05%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 573 million in 2023 from 563 million in 2022 representing a change of 1.84%. This indicates an increase in overall debt burden.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001756390 | |||
| total assets | 895873000 | 929363000 | -3.60 |
| total liabilities | 806964000 | 811820000 | -0.60 |
| total equity | 88909000 | 117543000 | -24.36 |
| cash and cash equivalents | 65279000 | 83713000 | -22.02 |
| short term investments | 0 | 4677000 | -100.00 |
| long term investments | 0 | 5073000 | -100.00 |
| total current assets | 213578000 | 236264000 | -9.60 |
| total non current assets | 682295000 | 693099000 | -1.56 |
| total current liabilities | 145129000 | 103056000 | 40.83 |
| total non current liabilities | 661835000 | 708764000 | -6.62 |
| common stock | 215000 | 215000 | 0.00 |
| retained earnings | -383565000 | -355309000 | -7.95 |
| total debt | 578440000 | 580553000 | -0.36 |
Total Assets: Total Assets decreased to 896 million in 2024Q3 from 929 million in 2024Q2 representing a change of -3.6%. Suggesting a decrease in asset holdings.
Total Equity: Total Equity decreased to 89 million in 2024Q3 from 118 million in 2024Q2 representing a change of -24.36%. This indicates a decrease in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 65 million in 2024Q3 from 84 million in 2024Q2 representing a change of -22.02%. This indicates a decrease in available liquid assets.
Short Term Investments: Short Term Investments decreased to 0 million in 2024Q3 from 5 million in 2024Q2 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.
Total Current Assets: Total Current Assets decreased to 214 million in 2024Q3 from 236 million in 2024Q2 representing a change of -9.6%. This indicates a worsen liquidity position.
Total Current Liabilities: Total Current Liabilities increased to 145 million in 2024Q3 from 103 million in 2024Q2 representing a change of 40.83%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to -384 million in 2024Q3 from -355 million in 2024Q2 representing a change of -7.95%. This indicates an accumulated losses.
Total Liabilities: Total Liabilities decreased to 807 million in 2024Q3 from 812 million in 2024Q2 representing a change of -0.6%. This indicates a decrease in overall liabilities.
Total Debt: Total Debt decreased to 578 million in 2024Q3 from 581 million in 2024Q2 representing a change of -0.36%. This indicates a reduction in overall debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001756390 | |||
| net change in cash | -1638000 | -81335000 | 97.99 |
| operating cash flow | 75334000 | -38356000 | 296.41 |
| free cash flow | 35143000 | -164250000 | 121.40 |
| capital expenditure | -40191000 | -125894000 | 68.08 |
| depreciation and amortization | 60036000 | 38242000 | 56.99 |
| deferred income tax | -12250000 | -5755000 | -112.86 |
| stock based compensation | 19776000 | 18979000 | 4.20 |
| accounts payables | 26807000 | 12741000 | 110.40 |
| inventory | -14885000 | -43813000 | 66.03 |
| acquisitions net | -19857000 | -25140000 | 21.01 |
| investments in property plant and equipment | -24248000 | -125894000 | 80.74 |
| net cash used for investing activites | -59890000 | -114254000 | 47.58 |
| debt repayment | -23557000 | 81502000 | -128.90 |
| common stock issued | 7186000 | 0 | NaN |
| common stock repurchased | 0 | -5229000 | 100.00 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -17082000 | 71275000 | -123.97 |
| cash at end of period | 72508000 | 74146000 | -2.21 |
| accounts receivables | -14197000 | -6477000 | -119.19 |
| cash at beginning of period | 74146000 | 155481000 | -52.31 |
Net Change in Cash: Net Change in Cash increased to -2 million in 2023 from -81 million in 2022 representing a change of 97.99%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 75 million in 2023 from -38 million in 2022 representing a change of 296.41%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 35 million in 2023 from -164 million in 2022 representing a change of 121.4%. This indicates an increase in cash generated after accounting for capital expenditures.
Accounts Receivables: Accounts Receivables decreased to -14 million in 2023 from -6 million in 2022 representing a change of -119.19%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Capital Expenditure: Capital Expenditure increased to -40 million in 2023 from -126 million in 2022 representing a change of 68.08%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Stock-Based Compensation: Stock-Based Compensation increased to 20 million in 2023 from 19 million in 2022 representing a change of 4.2%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables increased to 27 million in 2023 from 13 million in 2022 representing a change of 110.4%. This indicates that the company has increased its outstanding obligations to its suppliers.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001756390 | |||
| operating cash flow | 1972000 | 32253999 | -93.89 |
| free cash flow | -9450000 | 25896999 | -136.49 |
| capital expenditure | -11422000 | -6357000 | -79.68 |
| depreciation and amortization | 17322000 | 0 | NaN |
| deferred income tax | -4699000 | -2210000 | -112.62 |
| stock based compensation | -195000 | -4448000 | 95.62 |
| accounts receivables | -3462000 | 585000 | -691.79 |
| accounts payables | -2990000 | 2981000 | -200.30 |
| inventory | 3963000 | 3641000 | 8.84 |
| acquisitions net | 189000 | -10000000 | 101.89 |
| investments in property plant and equipment | 16538000 | -5357000 | 408.72 |
| net cash used for investing activites | -11141000 | -16875000 | 33.98 |
| debt repayment | 2287000 | -122000 | 1974.59 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | 5060000 | -4448000 | 213.76 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -9265000 | -4570000 | -102.74 |
| net change in cash | -18434000 | 10809000 | -270.54 |
| cash at end of period | 65279000 | 83713000 | -22.02 |
| cash at beginning of period | 83713000 | 72904000 | 14.83 |
Net Change in Cash: Net Change in Cash decreased to -18 million in 2024Q3 from 11 million in 2024Q2 representing a change of -270.54%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow decreased to 2 million in 2024Q3 from 32 million in 2024Q2 representing a change of -93.89%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to -9 million in 2024Q3 from 26 million in 2024Q2 representing a change of -136.49%. This indicates a decrease in cash generated after accounting for capital expenditures.
Stock-Based Compensation: Stock-Based Compensation increased to 0 million in 2024Q3 from -4 million in 2024Q2 representing a change of 95.62%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables increased to 3 million in 2024Q3 from 3 million in 2024Q2 representing a change of -200.3%. This indicates that the company has increased its outstanding obligations to its suppliers.
Capital Expenditure: Capital Expenditure decreased to -11 million in 2024Q3 from -6 million in 2024Q2 representing a change of -79.68%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Accounts Receivables: Accounts Receivables decreased to -3 million in 2024Q3 from 1 million in 2024Q2 representing a change of -691.79%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 2.6 | 2.21 | 17.64 |
| net income per share | -0.24 | -0.44 | 45.12 |
| operating cash flow per share | 0.38 | -0.21 | 280.85 |
| free cash flow per share | 0.18 | -0.9 | 119.70 |
| cash per share | 0.41 | 0.42 | -2.57 |
| book value per share | 0.72 | 0.89 | -19.50 |
| tangible book value per share | -0.63 | -0.56 | -13.80 |
| shareholders equity per share | 0.72 | 0.89 | -19.50 |
| interest debt per share | 3.07 | 3.24 | -5.26 |
| market cap | 199154000 | 210888150.0 | -5.56 |
| enterprise value | 700106000 | 699817150 | 0.04 |
| pe ratio | -4.13 | -2.61 | -58.46 |
| price to sales ratio | 0.38 | 0.52 | -26.08 |
| pocfratio | 2.64 | -5.5 | 148.08 |
| pfcf ratio | 5.67 | -1.28 | 541.37 |
| pb ratio | 1.39 | 1.29 | 8.01 |
| ptb ratio | 1.39 | 1.29 | 8.01 |
| ev to sales | 1.35 | 1.72 | -21.69 |
| enterprise value over ebitda | 8.51 | 25.56 | -66.71 |
| ev to operating cash flow | 9.29 | -18.25 | 150.94 |
| ev to free cash flow | 19.92 | -4.26 | 567.57 |
| earnings yield | -0.24 | -0.38 | 36.89 |
| free cash flow yield | 0.18 | -0.78 | 122.66 |
| debt to equity | 4.01 | 3.45 | 16.49 |
| debt to assets | 0.62 | 0.65 | -3.40 |
| net debt to ebitda | 6.09 | 17.86 | -65.90 |
| current ratio | 2.47 | 1.79 | 37.84 |
| interest coverage | -0.1 | -0.05 | -107.76 |
| income quality | -1.56 | 0.47 | -429.55 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.24 | 0.29 | -17.89 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.29 | 0.3 | -3.89 |
| capex to operating cash flow | 0.53 | -3.28 | 116.25 |
| capex to revenue | 0.08 | 0.31 | -75.01 |
| capex to depreciation | 0.67 | 3.29 | -79.66 |
| stock based compensation to revenue | 0.04 | 0.05 | -18.44 |
| graham number | 1.98 | 2.97 | -33.53 |
| roic | -0.01 | -0.0 | -271.53 |
| return on tangible assets | -0.07 | -0.13 | 44.42 |
| graham net net | -3.09 | -3.1 | 0.62 |
| working capital | 136174000 | 87794000 | 55.11 |
| tangible asset value | -126118000 | -102048000 | -23.59 |
| net current asset value | -547818000 | -510002000 | -7.41 |
| invested capital | 803802000 | 741927000 | 8.34 |
| average receivables | 30617500 | 14899500 | 105.49 |
| average payables | 25876000 | 11300500 | 128.98 |
| average inventory | 96413000 | 81560000 | 18.21 |
| days sales outstanding | 30.65 | 15.9 | 92.72 |
| days payables outstanding | 34.83 | 22.95 | 51.75 |
| days of inventory on hand | 95.7 | 131.19 | -27.05 |
| receivables turnover | 11.91 | 22.95 | -48.11 |
| payables turnover | 10.48 | 15.9 | -34.10 |
| inventory turnover | 3.81 | 2.78 | 37.09 |
| roe | -0.34 | -0.5 | 31.83 |
| capex per share | 0.2 | 0.69 | -70.60 |
ROE: Return on Equity (ROE) increased to -0.34 on 2023-12-31 from -0.50 on 2022-12-31, representing a change of 31.83%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -4.13 on 2023-12-31 from -2.61 on 2022-12-31, representing a change of -58.46%. Indicating a decrease in the relative valuation of the company's stock.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 4.01 on 2023-12-31 from 3.45 on 2022-12-31, representing a change of 16.49%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. A ratio of 2.0 or higher is usually considered risky.
Current Ratio: Current Ratio increased to 2.47 on 2023-12-31 from 1.79 on 2022-12-31, representing a change of 37.84%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| AAWH | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 0.66 | 0.66 | -0.45 |
| net income per share | -0.13 | -0.1 | -29.03 |
| operating cash flow per share | 0.01 | 0.15 | -93.92 |
| free cash flow per share | -0.04 | 0.12 | -136.30 |
| cash per share | 0.3 | 0.41 | -26.54 |
| book value per share | 0.41 | 0.55 | -24.76 |
| tangible book value per share | -0.81 | -0.7 | -15.69 |
| shareholders equity per share | 0.41 | 0.55 | -24.78 |
| interest debt per share | 2.75 | 2.76 | -0.47 |
| market cap | 180217890 | 193975600 | -7.09 |
| enterprise value | 693378890 | 690815600 | 0.37 |
| pe ratio | -1.59 | -2.23 | 28.37 |
| price to sales ratio | 1.27 | 1.37 | -7.17 |
| pocfratio | 91.39 | 6.01 | 1419.59 |
| pfcf ratio | -19.07 | 7.49 | -354.61 |
| pb ratio | 2.05 | 1.67 | 22.87 |
| ptb ratio | 2.05 | 1.67 | 22.87 |
| ev to sales | 4.9 | 4.88 | 0.29 |
| enterprise value over ebitda | 71.99 | 45.48 | 58.29 |
| ev to operating cash flow | 351.61 | 21.42 | 1541.67 |
| ev to free cash flow | -73.37 | 26.68 | -375.06 |
| earnings yield | -0.16 | -0.11 | -39.61 |
| free cash flow yield | -0.05 | 0.13 | -139.28 |
| debt to equity | 6.57 | 4.98 | 31.77 |
| debt to assets | 0.65 | 0.62 | 3.36 |
| net debt to ebitda | 53.28 | 32.71 | 62.89 |
| current ratio | 1.47 | 2.29 | -35.81 |
| interest coverage | -0.22 | -0.18 | -23.15 |
| income quality | -0.07 | -1.48 | 95.29 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.33 | 0.24 | 38.24 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.29 | 0.29 | 2.03 |
| capex to operating cash flow | 5.79 | 0.2 | 2838.78 |
| capex to revenue | 0.08 | 0.04 | 79.54 |
| capex to depreciation | 0.66 | 0 | NaN |
| stock based compensation to revenue | -0.0 | -0.03 | 95.62 |
| graham number | 1.1 | 1.12 | -1.49 |
| roic | -0.0 | -0.0 | -11.20 |
| return on tangible assets | -0.04 | -0.03 | -35.66 |
| graham net net | -3.08 | -3.01 | -2.36 |
| working capital | 68449000 | 133208000 | -48.61 |
| tangible asset value | -172881000 | -148642000 | -16.31 |
| net current asset value | -593386000 | -575556000 | -3.10 |
| invested capital | 732506000 | 806416000 | -9.17 |
| average receivables | 42585500 | 40849500 | 4.25 |
| average payables | 33456000 | 36992500 | -9.56 |
| average inventory | 100608000 | 105324000 | -4.48 |
| days sales outstanding | 28.28 | 25.85 | 9.39 |
| days payables outstanding | 26.97 | 33.82 | -20.25 |
| days of inventory on hand | 89.51 | 93.48 | -4.25 |
| receivables turnover | 3.18 | 3.48 | -8.58 |
| payables turnover | 3.34 | 2.66 | 25.39 |
| inventory turnover | 1.01 | 0.96 | 4.43 |
| roe | -0.32 | -0.19 | -71.54 |
| capex per share | 0.05 | 0.03 | 78.73 |
ROE: Return on Equity (ROE) decreased to -0.32 on 2024-09-30 Q3 from -0.19 on 2024-06-30 Q2, representing a change of -71.54%. Suggesting that the company has not been generating high returns for its shareholders.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 6.57 on 2024-09-30 Q3 from 4.98 on 2024-06-30 Q2, representing a change of 31.77%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. A ratio of 2.0 or higher is usually considered risky.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to -1.59 on 2024-09-30 Q3 from -2.23 on 2024-06-30 Q2, representing a change of 28.37%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 1.47 on 2024-09-30 Q3 from 2.29 on 2024-06-30 Q2, representing a change of -35.81%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2025-01-15 09:36:30
Many cannabis investors seek ways to maximize their growth potential in the space. What this means right now is that the space as a whole is constantly trading with low-end volatility. This makes it difficult to see gains or even find the silver lining to wanting to find marijuana stocks to buy. But even as the public sector continues to struggle outside of it businesses are doing well.
Sentiment: Positive
Publish Date: 2025-01-14 08:00:00
NEW YORK , Jan. 14, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, is pleased to announce it has closed its previously announced private placement of $15 million of its 12.75% Senior Secured Notes due 2029 (the "Notes"). The Notes form part of the same series of the $235 million aggregate principal amount of the Company's 12.75% senior secured notes due 2029 issued on July 16, 2024.
Sentiment: Positive
Publish Date: 2025-01-10 19:09:00
NEW YORK , Jan. 10, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, is pleased to announce it has entered into an agency agreement with Seaport Global Securities LLC (the "Agent") on January 10, 2025, in connection with a proposed private placement of $15 million of its 12.75% Senior Secured Notes due 2029 (the "Notes"). The Notes will form part of the same series of the $235 million aggregate principal amount of the Company's 12.75% senior secured notes due 2029 issued on July 16, 2024.
Sentiment: Positive
Publish Date: 2024-12-27 17:00:00
MORRISTOWN, N.J. , Dec. 27, 2024 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," or the "Company" or "Ascend") (CSE: AAWH.U) (OTCQX: AAWH), a vertically integrated multi-state cannabis operator focused on bettering lives through cannabis, today announced it has received authorization from the Company's Board of Directors to commence a share buyback program ("Buyback Program").
Sentiment: Positive
Publish Date: 2024-12-17 17:00:00
Receives Consent from its Term Loan Holders to Repurchase up to $5 Million of its Common Shares MORRISTOWN, N.J. , Dec. 17, 2024 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," or the "Company" or "Ascend") (CSE: AAWH.U) (OTCQX: AAWH), a vertically integrated multi-state cannabis operator focused on bettering lives through cannabis, today announced that it has completed the repurchase for cancellation of 11,000,000 shares of its Class A common stock (the "Purchased Shares"), representing over 5% of the outstanding Class A common stock, in a private transaction from an institutional investor.
Sentiment: Positive
Publish Date: 2024-12-10 10:00:56
The US cannabis industry continues to show significant growth potential as legalization efforts advance across states. Currently, the industry generates billions annually and is expected to surpass $40 billion by 2030. This growth is fueled by increasing consumer demand, the expansion of medical and recreational markets, and the ongoing push for federal reform. For investors, US marijuana stocks offer opportunities to capitalize on this dynamic sector. However, the cannabis market remains highly volatile. It is crucial to monitor regulatory developments and earnings reports for informed decisions. Technical analysis, such as identifying support and resistance levels, can provide insights into potential entry and exit points. Additionally, evaluating trading volume trends can indicate market sentiment.
Sentiment: Positive
Publish Date: 2024-12-06 09:39:32
More marijuana stock investors are focused on long-term gains. Now, if there is a chance to make a profit sooner, that's always a win. Yet with how volatile the sector can be, with more development comes the chance for better upward momentum. As more people look for ways to invest preparation is key. If you are new to investing you should take the steps to learn the basics.
Sentiment: Positive
Publish Date: 2024-11-12 14:10:26
Ascend Wellness Holdings, Inc (OTCQX:AAWH) Q3 2024 Results Conference Call November 12, 2024 8:30 AM ET Company Participants Rebecca Koar - EVP of Investor Relation & Strategy Samuel Brill - Chief Executive Officer Frank Perullo - Co-Founder, President, and Director Roman Nemchenko - Chief Financial Officer Conference Call Participants Frederico Gomes - ATB Capital Markets Luke Hannan - Canaccord Genuity Russell Stanley - Beacon Securities Andrew Semple - Ventum Financial Operator Good morning, and thank you for standing by. Welcome to Ascend Wellness Holdings Third Quarter 2024 Earnings Call.
Sentiment: Negative
Publish Date: 2024-11-12 09:16:10
Ascend Wellness Holdings, Inc. (AAWH) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.05 per share a year ago.
Sentiment: Positive
Publish Date: 2024-11-12 07:00:00
Achieved $141.6 million Net Revenue in Q3 2024 Reported $25.1 million in Adjusted EBITDA Anticipates $30 million of Annual Savings Through Transformation Initiatives MORRISTOWN, N.J. , Nov. 12, 2024 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," or the "Company" or "Ascend") (CSE: AAWH.U) (OTCQX: AAWH), a vertically integrated multi-state cannabis operator focused on bettering lives through cannabis, today reported its financial results for the three months ended September 30, 2024 ("Q3 2024").
Sentiment: Positive
Publish Date: 2024-11-06 09:22:39
With Donald Trump as our newly elected president, how will marijuana stocks react? At this time many are concerned that Trump will not consider cannabis reform the way Kamala Harris might have. Which would be to push for federal reform and finally legitimize cannabis the way it should be, especially with more than half of the United States having legalized cannabis already.
Sentiment: Positive
Publish Date: 2024-10-31 10:00:21
With the U.S. cannabis industry experiencing steady growth, marijuana penny stocks have gained significant attention among investors. The industry generated over $25 billion in sales in 2023 and is projected to reach $45 billion by 2025, driven by ongoing legalization efforts and rising demand. Recent headlines highlight states like Ohio and Florida moving closer to full legalization, signaling the potential for even broader expansion. Many investors are taking note of these developments, hoping to capitalize on the growth in this emerging market. Penny stocks in the cannabis sector, though volatile, present attractive opportunities for high returns when researched carefully.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
